Internal Medicine · Alhambra, CA
NPI
1003835679
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
841 W Valley Blvd Ste 107
Alhambra, CA, 91803
Phone (626) 282-3657
Groups this clinician bills Medicare through
Medicare paid, 2024
$161K
2,462 services
Medicare patients, 2024
270
Average age 76
Drug cost, 2024
$3.6M
20,549 prescriptions
Company payments, 2025
$5,911
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nora K Tee was code 99213 (office e&m - established), 651 times for 247 patients. In total Nora K Tee billed 2,462 services in 28 codes, and Medicare paid $161K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 651 | 247 | $62.52 | $41K |
| 99214 Office E&M - Established | Office | 242 | 165 | $93.79 | $23K |
| 99497 Care Management/Coordination | Office | 216 | 216 | $81.00 | $17K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 197 | 197 | $140.24 | $28K |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 193 | 193 | $21.09 | $4,071 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 193 | 193 | $21.09 | $4,070 |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 192 | 192 | $26.80 | $5,146 |
| G0008 Administration of influenza virus vaccine | Office | 133 | 130 | $34.87 | $4,638 |
| 90662 Vaccine Product | Office | 132 | 129 | $81.37 | $11K |
| 36410 Vascular | Office | 57 | 47 | $12.80 | $729 |
| 99443 Telephone Services | Office | 44 | 38 | $99.84 | $4,393 |
| 96372 Injection Administration | Office | 30 | 22 | $10.66 | $320 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 24 | 24 | $177.55 | $4,261 |
| J0897 Injection, denosumab, 1 mg | Office | 20 | 17 | $0.01 | $0.13 |
| 90677 Vaccine Product | Office | 12 | 12 | $290.55 | $3,487 |
By year: 2022 $158K for 2,405 services; 2023 $163K for 2,488 services; 2024 $161K for 2,462 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 26 | 25 | $8.40 | $218 |
Medicare prescription drug claims, 2024
In 2024, the drug Nora K Tee prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,691 prescriptions and refills. In total Nora K Tee wrote 20,549 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,691 | 4,451 | 422 | $14K |
| Amlodipine Besylate Generic | 1,209 | 3,073 | 302 | $5,034 |
| Losartan Potassium Generic | 960 | 2,512 | 246 | $8,022 |
| Levocetirizine Dihydrochloride Generic | 948 | 2,154 | 324 | $8,888 |
| Levothyroxine Sodium Generic | 648 | 1,530 | 139 | $7,603 |
| Vascepa Icosapent Ethyl | 638 | 1,303 | 142 | $414K |
| Raloxifene Hcl Generic | 552 | 1,376 | 140 | $18K |
| Rosuvastatin Calcium Generic | 484 | 1,241 | 136 | $5,809 |
| Metformin Hcl Er Metformin Hcl | 433 | 1,142 | 113 | $3,962 |
| Gabapentin Generic | 402 | 691 | 131 | $3,120 |
| Alendronate Sodium Generic | 374 | 990 | 116 | $3,351 |
| Metoprolol Succinate Generic | 338 | 813 | 81 | $4,753 |
| Omeprazole Generic | 321 | 715 | 89 | $2,377 |
| Tamsulosin Hcl Generic | 315 | 814 | 83 | $4,931 |
| Pantoprazole Sodium Generic | 297 | 660 | 81 | $2,165 |
Brand drugs: 3,821 claims; generic drugs: 16,591 claims; opioid claims: 24.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nora K Tee $5,911 ($5,911 in general payments such as food, travel and fees) from 17 companies. The largest payer was Gilead Sciences, Inc. with $4,340.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 10 | $4,340 |
| Novo Nordisk Inc NVO | 11 | $372 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $229 |
| Abbvie Inc. ABBV | 8 | $186 |
| Abbott Laboratories ABT | 5 | $114 |
| GlaxoSmithKline, LLC. GSK | 4 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $83.66 |
| Aimmune Therapeutics, Inc. | 3 | $80.99 |
| Exact Sciences Corporation EXAS | 3 | $78.62 |
| Pfizer Inc. PFE | 3 | $58.94 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.